Back to Scientific and Special Advisors

Andrew Singleton, PhD - Scientific Advisory Board
Chief, Molecular Genetics Unit
Laboratory of Neurogenetics
National Institute on Aging/NIH
Bethesda, Maryland

Andrew Singleton received his BSc from the University of Sunderland, UK, and his PhD from the University of Newcastle upon Tyne, UK. Dr. Singleton's research initially focused on genetic determinants of dementia, in particular Alzheimer's disease and dementia with Lewy bodies. His postdoctoral studies were spent at the Mayo Clinic in Jacksonville Florida. In 2001 he moved to the National Institute on Aging at NIH, Bethesda, Maryland, and became principal investigator leading the Molecular Genetics Unit in 2002.

Dr. Singleton's laboratory studies the genetic basis of neurological disorders including Parkinson's disease. This research is performed using a variety of methodologies, including family based linkage and positional cloning in addition to genome-wide association. The goal of Dr. Singleton's research is to identify genetic variability that causes or contributes to Parkinson's disease in order to facilitate understanding of the molecular processes underlying disease.